CellSeed Inc. (TYO:7776)
Japan · Delayed Price · Currency is JPY 190.00
+1.00 (0.53%)
Oct 26, 2026, 3:30 PM JST
CellSeed Market Cap
CellSeed has a market cap or net worth of 7.5 billion as of October 26, 2026. It is the 30,516th most valuable company in the world and the 2,755th biggest in Japan. Its market cap has decreased by 49.69% in one year.
Market Cap
7.50B
Enterprise Value
n/a
Revenue
161.00M
Global Rank
Country Rank
#2,755 Japan
PE Ratio
n/a
ChartMarket Cap Chart
Since March 16, 2010, CellSeed's market cap has increased from 5.26B to 7.50B, an increase of 42.50%. That is a compound annual growth rate of 2.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 7.50B | -16.47% |
| Dec 30, 2025 | 8.98B | -35.09% |
| Dec 30, 2024 | 13.83B | 62.71% |
| Dec 29, 2023 | 8.50B | 107.22% |
| Dec 30, 2022 | 4.10B | 25.55% |
| Dec 30, 2021 | 3.27B | -13.46% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Carna Biosciences | 8.07B |
| K Pharma,Inc. | 7.93B |
| Kidswell Bio | 7.44B |
| OncoTherapy Science | 7.35B |
| J-Pharma | 7.32B |
| Chiome Bioscience | 7.10B |
| StemCell Institute | 7.07B |
| Nano Holdings | 6.98B |